These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
57 related articles for article (PubMed ID: 3573331)
41. Preliminary in vivo evaluation of a nanofiltered factor IX concentrate. Mannucci PM; Tradati F Thromb Haemost; 1995 Apr; 73(4):737-8. PubMed ID: 7495096 [No Abstract] [Full Text] [Related]
42. Role of vector in activation of T cell subsets in immune responses against the secreted transgene product factor IX. Fields PA; Kowalczyk DW; Arruda VR; Armstrong E; McCleland ML; Hagstrom JN; Pasi KJ; Ertl HC; Herzog RW; High KA Mol Ther; 2000 Mar; 1(3):225-35. PubMed ID: 10933938 [TBL] [Abstract][Full Text] [Related]
43. Labeled factor IX kinetics in patients with hemophilia-B. Smith KJ; Thompson AR Blood; 1981 Sep; 58(3):625-9. PubMed ID: 7259841 [TBL] [Abstract][Full Text] [Related]
44. Factor IX activation by factor XIa proceeds without release of a free intermediate. Wolberg AS; Morris DP; Stafford DW Biochemistry; 1997 Apr; 36(14):4074-9. PubMed ID: 9100000 [TBL] [Abstract][Full Text] [Related]
46. [Population and molecular-genetic aspects of hemophilia A and B in Uzbekistan]. Boboev KT Tsitol Genet; 2008; 42(2):51-4. PubMed ID: 18630121 [TBL] [Abstract][Full Text] [Related]
47. A factor IX gene probe: its use in carrier detection, antenatal diagnosis and characterisation of the molecular basis for hemophilia B. Trent RJ; Svirklys L; Power PA; Rickard KA; Lammi A; Kronenberg H Aust N Z J Med; 1985 Dec; 15(6):721-6. PubMed ID: 3869438 [TBL] [Abstract][Full Text] [Related]
48. Variants of haemophilia B. Elödi S; Puskás E Thromb Diath Haemorrh; 1972 Dec; 28(3):489-95. PubMed ID: 4675270 [No Abstract] [Full Text] [Related]
49. The prophylactic treatment of hemophilia B Leyden with anabolic steroids. Briët E; Wijnands MC; Veltkamp JJ Ann Intern Med; 1985 Aug; 103(2):225-6. PubMed ID: 4014904 [No Abstract] [Full Text] [Related]
50. Massive hemorrhage into the iliopsoas muscle. Miyazaki K; Higashihara M Intern Med; 2005 Feb; 44(2):158-9. PubMed ID: 15750281 [No Abstract] [Full Text] [Related]
51. Pharmacokinetics of factor IX. Smith K Blood; 1986 Oct; 68(4):979-80. PubMed ID: 3756354 [No Abstract] [Full Text] [Related]
52. Proceedings: Immunochemical characterization of a factor IX inhibitor following anamnestic response. Roberts HR; Fuller CR; Worden H; Stuart J; Reisner H; Koehler H; Yount WJ Thromb Diath Haemorrh; 1975 Sep; 34(1):322. PubMed ID: 1188732 [No Abstract] [Full Text] [Related]
53. Formation and properties of a thrombin generated factor IX inhibitor. Marlar RA; Seegers WH Thromb Res; 1979 Jan; 14(1):95-105. PubMed ID: 570744 [No Abstract] [Full Text] [Related]
54. A novel one-step purification of mouse factor IX. Pilli VS; Plautz WE; Monroe DM; Majumder R Thromb Res; 2016 Mar; 139():125-6. PubMed ID: 26916308 [No Abstract] [Full Text] [Related]
55. [A simple analytic method of the activation mechanism of factor IX using Western blotting]. Sakai T; Ohkubo Y; Tanaka I; Yamamoto K; Yoshioka A; Fukui H Rinsho Ketsueki; 1987 Jan; 28(1):47-52. PubMed ID: 3573331 [No Abstract] [Full Text] [Related]